TY - JOUR
T1 - Gram-negative bacteraemia in non-ICU patients
T2 - Factors associated with inadequate antibiotic therapy and impact on outcomes
AU - Marschall, Jonas
AU - Agniel, Denis
AU - Fraser, Victoria J.
AU - Doherty, Joshua
AU - Warren, David K.
N1 - Funding Information:
J. M. received a research grant from the Swiss National Science Foundation (PBBSB-113014). D. K. W. (K23 AI050585-02) and V. J. F. (IK24 AI 06779401) are funded through NIH grants. D. K. W. and V. J. F. received a CDC Prevention Epicenter Programme grant (CDC 1U1CI000033301). The study was performed without industry support.
Funding Information:
D. K. W. is a Consultant for 3M Healthcare, Novabay Pharmaceuticals and Enturia, Inc., and receives research funding from Sage Products, Inc. and 3M Healthcare. V. J. F. is a Consultant for Steris and Verimetrix, and Member of the Speakers Bureau for Pfizer, Merck and Cubist Pharmaceuticals. All other authors have no conflict of interest to declare.
PY - 2008/6
Y1 - 2008/6
N2 - Background: A considerable number of Gram-negative bacteraemias occur outside intensive care units (ICUs). Inadequate antibiotic therapy in ICUs has been associated with adverse outcomes; however, there are no prospective studies in non-ICU patients. Methods: A 6 month (1 August 2006-31 January 2007), prospective cohort study of non-ICU patients with Gram-negative bacteraemia in a tertiary-care hospital was performed. Inadequate empirical antibiotic therapy was defined as no antibiotic or starting a non-susceptible antibiotic within 24 h after the initial positive blood culture. Results: Two hundred and fifty non-ICU patients had Gram-negative bacteraemia. The mean age was 56.4 (±16.1) years. The predominant bacteria in monomicrobial infections were Escherichia coli (24%), Klebsiella pneumoniae (18%) and Pseudomonas aeruginosa (8%). Sixty-one (24%) patients had polymicrobial bacteraemia. Seventy patients (28%) required ICU transfer and 35 (14%) died. Seventy-nine (31.6%) received inadequate empirical antibiotic therapy. These patients were more likely to have a hospital-acquired infection [odds ratio (OR) = 1.99, 95% confidence interval (CI) = 1.11-3.56, P = 0.02] and less likely to have E. coli monomicrobial bacteraemia [OR 0.40 (95% CI 0.19-0.86), P = 0.02]. There were no differences in occurrence of sepsis [72 (91.1%) patients with inadequate versus 159 (93.0%) with adequate therapy; P = 0.6], ICU transfer [20 (25.3%) versus 50 (29.2%); P = 0.5], post-bacteraemia length of stay (median = 6.8 versus 6.1 days; P = 0.09) or death [11 (13.9%) versus 24 (14.0%); P = 1.0]. Conclusions: Nearly one-third of the non-ICU patients with Gram-negative bacteraemia received inadequate empirical antibiotic therapy. There was no difference in adverse outcomes between patients receiving inadequate or adequate therapy in this study.
AB - Background: A considerable number of Gram-negative bacteraemias occur outside intensive care units (ICUs). Inadequate antibiotic therapy in ICUs has been associated with adverse outcomes; however, there are no prospective studies in non-ICU patients. Methods: A 6 month (1 August 2006-31 January 2007), prospective cohort study of non-ICU patients with Gram-negative bacteraemia in a tertiary-care hospital was performed. Inadequate empirical antibiotic therapy was defined as no antibiotic or starting a non-susceptible antibiotic within 24 h after the initial positive blood culture. Results: Two hundred and fifty non-ICU patients had Gram-negative bacteraemia. The mean age was 56.4 (±16.1) years. The predominant bacteria in monomicrobial infections were Escherichia coli (24%), Klebsiella pneumoniae (18%) and Pseudomonas aeruginosa (8%). Sixty-one (24%) patients had polymicrobial bacteraemia. Seventy patients (28%) required ICU transfer and 35 (14%) died. Seventy-nine (31.6%) received inadequate empirical antibiotic therapy. These patients were more likely to have a hospital-acquired infection [odds ratio (OR) = 1.99, 95% confidence interval (CI) = 1.11-3.56, P = 0.02] and less likely to have E. coli monomicrobial bacteraemia [OR 0.40 (95% CI 0.19-0.86), P = 0.02]. There were no differences in occurrence of sepsis [72 (91.1%) patients with inadequate versus 159 (93.0%) with adequate therapy; P = 0.6], ICU transfer [20 (25.3%) versus 50 (29.2%); P = 0.5], post-bacteraemia length of stay (median = 6.8 versus 6.1 days; P = 0.09) or death [11 (13.9%) versus 24 (14.0%); P = 1.0]. Conclusions: Nearly one-third of the non-ICU patients with Gram-negative bacteraemia received inadequate empirical antibiotic therapy. There was no difference in adverse outcomes between patients receiving inadequate or adequate therapy in this study.
KW - Antibacterial agents
KW - Bloodstream infection
KW - Gram-negative bacteria
KW - Mortality
KW - Non-intensive care
UR - http://www.scopus.com/inward/record.url?scp=44449165421&partnerID=8YFLogxK
U2 - 10.1093/jac/dkn104
DO - 10.1093/jac/dkn104
M3 - Article
C2 - 18344548
AN - SCOPUS:44449165421
SN - 0305-7453
VL - 61
SP - 1376
EP - 1383
JO - Journal of Antimicrobial Chemotherapy
JF - Journal of Antimicrobial Chemotherapy
IS - 6
ER -